9174826

Source:http://linkedlifedata.com/resource/pubmed/id/9174826

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0012634, umls-concept:C0035359, umls-concept:C0205179, umls-concept:C0281548, umls-concept:C0442967, umls-concept:C0443268, umls-concept:C0677886
pubmed:issue	3
pubmed:dateCreated	1997-7-31
pubmed:abstractText	The objective of this study was to evaluate the impact of retroperitoneal lymph node disease on the efficacy of salvage intraperitoneal (IP) chemotherapy for advanced epithelial ovarian cancer.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8100357
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antimetabolites, Antineoplastic, http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Phytogenic, http://linkedlifedata.com/resource/pubmed/chemical/Carboplatin, http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin, http://linkedlifedata.com/resource/pubmed/chemical/Cytarabine, http://linkedlifedata.com/resource/pubmed/chemical/Etoposide, http://linkedlifedata.com/resource/pubmed/chemical/Mitoxantrone
pubmed:status	MEDLINE
pubmed:issn	0392-2936
pubmed:author	pubmed-author:BarakatR RRR, pubmed-author:BrownCC, pubmed-author:CurtisJ SJS, pubmed-author:FennellyDD, pubmed-author:PizzutoFF, pubmed-author:VenkatramanE SES
pubmed:issnType	Print
pubmed:volume	18
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	161-3
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:9174826-Adult, pubmed-meshheading:9174826-Aged, pubmed-meshheading:9174826-Antimetabolites, Antineoplastic, pubmed-meshheading:9174826-Antineoplastic Agents, pubmed-meshheading:9174826-Antineoplastic Agents, Phytogenic, pubmed-meshheading:9174826-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:9174826-Biopsy, Needle, pubmed-meshheading:9174826-Carboplatin, pubmed-meshheading:9174826-Carcinoma, pubmed-meshheading:9174826-Cisplatin, pubmed-meshheading:9174826-Combined Modality Therapy, pubmed-meshheading:9174826-Cytarabine, pubmed-meshheading:9174826-Etoposide, pubmed-meshheading:9174826-Female, pubmed-meshheading:9174826-Follow-Up Studies, pubmed-meshheading:9174826-Humans, pubmed-meshheading:9174826-Injections, Intraperitoneal, pubmed-meshheading:9174826-Laparotomy, pubmed-meshheading:9174826-Lymphatic Metastasis, pubmed-meshheading:9174826-Middle Aged, pubmed-meshheading:9174826-Mitoxantrone, pubmed-meshheading:9174826-Neoplasm Staging, pubmed-meshheading:9174826-Ovarian Neoplasms, pubmed-meshheading:9174826-Retroperitoneal Space, pubmed-meshheading:9174826-Retrospective Studies, pubmed-meshheading:9174826-Salvage Therapy, pubmed-meshheading:9174826-Survival Rate, pubmed-meshheading:9174826-Treatment Outcome
pubmed:year	1997
pubmed:articleTitle	Salvage intraperitoneal therapy of advanced epithelial ovarian cancer: impact of retroperitoneal nodal disease.
pubmed:affiliation	Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.
pubmed:publicationType	Journal Article, Comparative Study